Yeli Wang
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Epidemiology 11
- Adipokines, Inflammation, and Metabolic Diseases 7
- Liver Disease Diagnosis and Treatment 4
- Co-authors
- An Pan (15 shared papers)Frank Hu (4 shared papers)Mohammad Talaei (3 shared papers)Tazeen H. Jafar (10 shared papers)Monica Palanichamy Kala (1 shared paper)Woon‐Puay Koh (16 shared papers)Tangchun Wu (1 shared paper)Jian‐Min Yuan (11 shared papers)
- Journals
- Diabetes & Metabolism Journal (3 papers)BMC Nephrology (2 papers)Diagnostic Pathology (2 papers)PLoS ONE (2 papers)Kidney Medicine (2 papers)
- Partner nations
- United StatesSingaporeChina
In The Last Decade
Yeli Wang
46 papers receiving 1.9k citations
Yeli Wang's Hit Papers
Peers
Comparison fields: 5 of 112
- Endocrinology, Diabetes and Metabolism 399
- Nephrology 117
- Physiology 274
- Clinical Psychology 231
- Epidemiology 204
Countries citing papers authored by Yeli Wang
This map shows the geographic impact of Yeli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeli Wang more than expected).
Fields of papers citing papers by Yeli Wang
This network shows the impact of papers produced by Yeli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeli Wang. The network helps show where Yeli Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yeli Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis Hit paper breakdown → | 2015 | 442 |
| 2 | 2020 | 291 | |
| 3 | 2015 | 258 | |
| 4 | 2016 | 136 | |
| 5 | Associations between plant-based dietary patterns and risks of type 2 diabetes, cardiovascular disease, cancer, and mortality – a systematic review and meta-analysis Hit paper breakdown → | 2023 | 129 |
| 6 | 2018 | 85 | |
| 7 | 2017 | 64 | |
| 8 | 2016 | 58 | |
| 9 | 2023 | 41 | |
| 10 | 2019 | 40 | |
| 11 | 2014 | 34 | |
| 12 | 2017 | 34 | |
| 13 | 2021 | 33 | |
| 14 | 2017 | 28 | |
| 15 | 2019 | 23 | |
| 16 | 2022 | 23 | |
| 17 | 2021 | 21 | |
| 18 | 2020 | 20 | |
| 19 | 2021 | 20 | |
| 20 | 2017 | 18 |
About Yeli Wang
Yeli Wang is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Nephrology, Physiology and Cancer Research, having authored 48 papers that have together received 2k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Chronic Kidney Disease and Diabetes (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Nutritional Studies and Diet (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Smoking Behavior and Cessation (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (399 citations), Nephrology (117 citations), Physiology (274 citations), Clinical Psychology (231 citations) and Epidemiology (204 citations). Yeli Wang has collaborated with scholars based in United States, Singapore and China. Frequent co-authors include An Pan, Frank Hu, Mohammad Talaei, Tazeen H. Jafar, Monica Palanichamy Kala, Woon‐Puay Koh, Tangchun Wu, Jian‐Min Yuan, Yonghai Lu and Choon Nam Ong. Their work appears in journals such as Diabetes & Metabolism Journal, BMC Nephrology, Diagnostic Pathology, PLoS ONE and Kidney Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.